Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat - PubMed (original) (raw)
Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat
Frank Y Ma et al. Lab Invest. 2009 Apr.
Free article
Abstract
Macrophages induce acute renal injury in anti-glomerular basement membrane (GBM) glomerulonephritis. This operates, in part, via activation of the c-Jun amino terminal kinase (JNK) signaling pathway. However, it is unknown whether inhibition of JNK signaling is effective once the proinflammatory response is established in the injured kidney. This study examined whether blockade of JNK signaling could halt disease progression, including crescent formation, in a model of severe crescentic anti-GBM glomerulonephritis. WKY rats were immunized with sheep IgG and then injected with sheep anti-GBM serum (day 0). Animals were treated with the JNK inhibitor, CC-401, vehicle alone, or no treatment from day 7 until being killed on day 24 of disease. Untreated animals at day 7 showed significant proteinuria, focal glomerular lesions, marked glomerular macrophage and T-cell accumulation, and upregulation of proinflammatory mediators (TNF-alpha, iNOS, MMP-12). Untreated and vehicle-treated groups displayed severe glomerulonephritis at day 24 with renal impairment and worsening proteinuria. These animals had severe glomerular lesions, with 60% of glomeruli exhibiting fibrocellular crescents, in association with increased macrophage and T-cell accumulation (including macrophage giant cells) and a further increase in mRNA levels of TNF-alpha, iNOS, MMP-12, and TGF-beta1. In contrast, CC-401 treatment prevented renal impairment, suppressed proteinuria, and prevented severe glomerular and tubulointerstitial lesions, including crescent formation and granulomatous-like lesions. These protective effects were independent of glomerular macrophage and T-cell accumulation, and of the humoral immune response. CC-401 treatment inhibited expression of both pro- and antiinflammatory molecules (interleukin-10 and heme oxygenase-1). In addition, IL-1 induced MMP-12 and IL-10 production by cultured macrophages was found to be JNK dependent. In conclusion, blockade of JNK signaling provides substantial protection against the progression of crescentic anti-GBM glomerulonephritis, which may be, in part, due to inhibition of the macrophage proinflammatory response.
Similar articles
- A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis.
Flanc RS, Ma FY, Tesch GH, Han Y, Atkins RC, Bennett BL, Friedman GC, Fan JH, Nikolic-Paterson DJ. Flanc RS, et al. Kidney Int. 2007 Sep;72(6):698-708. doi: 10.1038/sj.ki.5002404. Epub 2007 Jun 27. Kidney Int. 2007. PMID: 17597698 - ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Amos LA, Ma FY, Tesch GH, Liles JT, Breckenridge DG, Nikolic-Paterson DJ, Han Y. Amos LA, et al. J Cell Mol Med. 2018 Sep;22(9):4522-4533. doi: 10.1111/jcmm.13705. Epub 2018 Jul 11. J Cell Mol Med. 2018. PMID: 29998485 Free PMC article. - c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ. Han Y, et al. Lab Invest. 2011 Jul;91(7):978-91. doi: 10.1038/labinvest.2011.61. Epub 2011 Apr 25. Lab Invest. 2011. PMID: 21519331 - Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G. Nishikawa K, et al. J Exp Med. 1993 Mar 1;177(3):667-77. doi: 10.1084/jem.177.3.667. J Exp Med. 1993. PMID: 8094735 Free PMC article. - The glomerular crescent: triggers, evolution, resolution, and implications for therapy.
Anguiano L, Kain R, Anders HJ. Anguiano L, et al. Curr Opin Nephrol Hypertens. 2020 May;29(3):302-309. doi: 10.1097/MNH.0000000000000596. Curr Opin Nephrol Hypertens. 2020. PMID: 32132388 Free PMC article. Review.
Cited by
- TGF‑β/Smad signaling in chronic kidney disease: Exploring post‑translational regulatory perspectives (Review).
Li J, Zou Y, Kantapan J, Su H, Wang L, Dechsupa N. Li J, et al. Mol Med Rep. 2024 Aug;30(2):143. doi: 10.3892/mmr.2024.13267. Epub 2024 Jun 21. Mol Med Rep. 2024. PMID: 38904198 Free PMC article. Review. - Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics.
Islamuddin M, Qin X. Islamuddin M, et al. Cell Death Discov. 2024 May 13;10(1):229. doi: 10.1038/s41420-024-01996-3. Cell Death Discov. 2024. PMID: 38740765 Free PMC article. Review. - Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy.
Wang S, Qin S, Cai B, Zhan J, Chen Q. Wang S, et al. Front Endocrinol (Lausanne). 2023 Jul 14;14:932649. doi: 10.3389/fendo.2023.932649. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37522131 Free PMC article. Review. - Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression.
Wang J, Li J, Zhang X, Zhang M, Hu X, Yin H. Wang J, et al. Front Mol Biosci. 2022 Sep 6;9:986405. doi: 10.3389/fmolb.2022.986405. eCollection 2022. Front Mol Biosci. 2022. PMID: 36148005 Free PMC article. Review. - c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease.
Smith AO, Jonassen JA, Preval KM, Davis RJ, Pazour GJ. Smith AO, et al. J Cell Signal. 2022;3(1):62-78. doi: 10.33696/Signaling.3.068. J Cell Signal. 2022. PMID: 35253003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous